June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Hyperosmotic Stress and Osmo-Gene Adaptation During Early Induction of Refractive Errors.
Author Affiliations & Notes
  • Sheila Gillard Crewther
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Nina Riddell
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Alan Marshall
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Loretta Giummarra
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Melanie Murphy
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Melinda Jane Goodyear
    Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • David P Crewther
    CHP, Swinburne University of Technology, Melbourne, VIC, Australia
  • Footnotes
    Commercial Relationships Sheila Crewther, None; Nina Riddell, None; Alan Marshall, None; Loretta Giummarra, None; Melanie Murphy, None; Melinda Goodyear, None; David Crewther, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2166. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sheila Gillard Crewther, Nina Riddell, Alan Marshall, Loretta Giummarra, Melanie Murphy, Melinda Jane Goodyear, David P Crewther, None; Hyperosmotic Stress and Osmo-Gene Adaptation During Early Induction of Refractive Errors.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2166.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Why is myopia a common risk factor for most sight threatening disorders? Our earlier biometric, ultrastructural and elemental analyses of the chick form deprivation model have provided evidence of severe physiological, oxidative and hyperosmotic stress. More recently prolonged hyperosmotic stress has been shown to lead to chronic inflammation in a number of diseases (Brocker etal 2013). We hypothesized that perturbation of axial growth during induction of refractive errors would also be accompanied by hyperosmosis and osmoadaptative gene changes, that should be demonstratable with elemental microanalysis (EDX) and RNA seq respectively.

Methods: Chicks were raised with ±10D lenses, or no lens. Following biometric measurements at 1, 2, and 3 days, 8 chicks per lens group were euthanized. RNA was extracted from the retina/RPE/choroid of 4. Four were used for scanning electron-microscopy and EDX. Libraries were sequenced on the Illumina HiSeq1500. Counts per million were imported into GSEA and expression of KEGG and Reactome pathways during myopia/hyperopia induction compared to age-matched no lens chicks (FDR cut-off <.25).

Results: Refractive compensation (RC) to -10D defocus continued for 72hrs whereas RC to +10D was in near completion after 24hours. EDX shows sodium and chloride ion distributions were greatly upregulated in outer retina by -10D over the 72hrs but only at the retino-vitreal border in +10D at 72hrs. Potassium profiles in RC to +10D remained upregulated across the retina for 72 hrs with concurrent up-regulation of reactome potassium channel pathways at 72hrs in RNAseq data. Consistent with altered osmotic and oxidative stress, implicated pathways during refractive compensation included those related to synthesis of small molecule osmolytes, structural remodelling, inflammation, and metabolism.

Conclusions: The EDX results demonstrate that RC to optical defocus is accompanied by hyperosmotic shifts in ion distribution profiles across the entire posterior eye, while concurrent changes in gene expression profiles were seen in metabolic and ion solute processes. These pathways have previously been associated with osmoadaptation and more severe disease states such as ARM and diabetes. The findings suggest the need for further experimental considerations of hyperosmotic changes as risk factors for severe visual impairments and for development of therapeutics.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×